| Title |
An open, multicenter Phase I study to evaluate the safety, tolerability, pharmacokinetics of DZD1516 in human epidermal growth factor Receptor 2-positive advanced breast cancer patients |
| Description |
An open, multicenter Phase I study to evaluate the safety, tolerability, pharmacokinetics, and initial antitumor activity of DZD1516 in combination with trastuzumab and capecitabine, or DZD1516 in combination with T-DM1, in human epidermal growth factor Receptor 2-positive advanced breast cancer patients |
| Organism |
Homo sapiens |
| Data Type |
Biomarker Data |
| Data Accessibility |
Controlled-access |
| BioProject |
PRJCA014815 |
| Release Date |
2024-12-31 |
| Submitter |
Xichun Hu (xchu2009@hotmail.com) |
| Organization |
Fudan University Shanghai Cancer Center |
| Submission Date |
2023-02-08 |